Virax Biolabs Group Limited (VRAX)

Mar 31, 2025, 2:57 PM EDT - 2 days ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 18, 2025, 7:30 AM EDT - 15 days ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 13, 2025, 7:30 AM EDT - 20 days ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 4 weeks ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Feb 25, 2025, 7:00 AM EST - 5 weeks ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Jan 23, 2025, 3:35 PM EST - 2 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Jan 13, 2025, 9:20 AM EST - 2 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Dec 17, 2024, 7:30 AM EST - 3 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 10, 2024, 7:30 AM EST - 4 months ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Oct 23, 2024, 7:30 AM EDT - 5 months ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Sep 16, 2024, 8:30 AM EDT - 7 months ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Sep 16, 2024, 8:30 AM EDT - 7 months ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Sep 9, 2024, 8:00 AM EDT - 7 months ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Aug 29, 2024, 9:03 AM EDT - 7 months ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 28, 2024, 2:18 PM EDT - 7 months ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 7:30 AM EDT - 7 months ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 23, 2024, 4:09 PM EDT - 7 months ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 8 months ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 10:20 AM EDT - 8 months ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs to Participate at ESCMID Global 2024

Mar 15, 2024, 4:30 PM EDT - 1 year ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Dec 21, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 14, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Sep 12, 2023, 7:30 AM EDT - 1 year ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 1, 2023, 7:30 AM EDT - 1 year ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Aug 3, 2023, 7:30 AM EDT - 1 year ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Jul 18, 2023, 7:30 AM EDT - 1 year ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

May 4, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Apr 19, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Mar 10, 2023, 5:17 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 2 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 7, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Feb 7, 2023, 9:15 AM EST - 2 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Feb 7, 2023, 8:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Feb 6, 2023, 4:05 PM EST - 2 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Jan 4, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Dec 6, 2022, 7:30 AM EST - 2 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Nov 15, 2022, 7:30 AM EST - 2 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 8, 2022, 4:30 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 3, 2022, 7:30 AM EDT - 2 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Oct 26, 2022, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Sep 22, 2022, 8:07 AM EDT - 2 years ago

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

COSM

Sep 12, 2022, 7:00 AM EDT - 2 years ago

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Sep 6, 2022, 4:00 PM EDT - 2 years ago

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Aug 16, 2022, 7:31 AM EDT - 2 years ago

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Jul 26, 2022, 8:00 AM EDT - 2 years ago

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Jul 25, 2022, 6:19 PM EDT - 2 years ago

Investors May Want to Follow Progress of VC-Backed Medtechs

BHC BLCO MDT MHUA TNON

Jul 21, 2022, 10:33 AM EDT - 2 years ago

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX